Elizabeth Garner
Publications by Year
Research Areas
CAR-T cell therapy research, CRISPR and Genetic Engineering, Biosimilars and Bioanalytical Methods, DNA Repair Mechanisms, T-cell and B-cell Immunology
Most-Cited Works
- → Mapping the genomic landscape of CRISPR–Cas9 cleavage(2017)458 cited
- → Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling(2012)391 cited
- → Human GEN1 and the SLX4-Associated Nucleases MUS81 and SLX1 Are Essential for the Resolution of Replication-Induced Holliday Junctions(2013)147 cited
- → Mre11–Rad50–Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activity(2008)129 cited
- → Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death(2008)120 cited
- → GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replication(2010)110 cited
- → Noncovalent Interactions with SUMO and Ubiquitin Orchestrate Distinct Functions of the SLX4 Complex in Genome Maintenance(2014)80 cited
- → Ubiquitylation and the Fanconi anemia pathway(2011)58 cited
- → Studying the DNA damage response using in vitro model systems(2009)45 cited
- → High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models(2024)29 cited